Hennion & Walsh Asset Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding IMGN
Hennion & Walsh Asset Management's IMGN Position: Q1 2024 in Review
Hennion & Walsh Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 356,997 shares — an estimated $10.6M sold.
Hennion & Walsh Asset Management first reported a position in IMGN in Q4 2021 and held it in 9 quarters. The position peaked at $10.6M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Hennion & Walsh Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Hennion & Walsh Asset Management sold 356,997 Immunogen Inc shares in Q1 2024, an estimated $10.6M.
- Hennion & Walsh Asset Management first reported a position in Immunogen Inc in Q4 2021 and held it in 9 quarters.
- Hennion & Walsh Asset Management's Immunogen Inc position peaked at $10.6M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Hennion & Walsh Asset Management's 13F filing for Q1 2024, filed 17 Apr 2024.